Invistics has been in the supply chain inventory management business for 20 years. They have been using a combination of optimization, machine learning, and analytics to address inventory management for years. Perhaps this background is what led to Invistics being the recipient of a grant from the National Institute of Health. They tested Invistics’ technology and its ability to detect, with greater efficiency and effectiveness, drug diversion by a healthcare worker. Today at the IFHDA conference, we listened to a speaker who was part of the Phase 1 trials, and she confirmed Flowlytics met those goals for her institution. Flowlytics uses artificial intelligence (AI) and although their different customers are not connected in terms of their data, they all get the advantage of the AI learning from each other.
I have spoken to more than one Flowlytics customer, each at various stages of implementation. All stated the Flowlytics’ team is responsive to their needs. This includes requests to design reports, including some that allow a more visual way of seeing the data. These clients stated other vendors were evaluated prior to their decision to select Flowlytics, and at the time each felt the technology Flowlytics offered provided the most out of the box functionality. In all cases, validation was done and Flowlytics identified previous known diversion cases in shorter time than the facilities’ current process (the range was a month to as long as a year earlier). Some of the client statements are as follows:
“The dashboard is clear, designed for use by an investigator where others are designed to give you data that you have to investigate.”
“It was a home-run that they have a way to alert you at home when there is a problem.”
“[In reference to the alerts] It will be a steep learning curve to what it all means”
‘Flowlytics is more sensitive and more accurate [than Rx Auditor] with flags which has reduced false positives”.
Flowlytics has the ability to look at controlled substance movement from the distributor to waste/return, but integration with the reverse distributor is not yet supported. Flowlytics is currently working on pulling data in from infusion pumps. It incorporates time and attendance into the feed as well as integrates with all major EMRs and ADMs and controlled substances (CS). Non-controlled substances can also be incorporated into the monitoring, and this solution can be applied throughout the facility including inpatient, outpatient, and procedural areas.